Vera Therapeutics Cash Flow Statement (2020-2026) | VERA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-5.85M	-7.25M	-16.60M	-17.11M	-14.92M	-24.82M	38.91M	-30.51M	-20.64M	-20.54M	55.73M	-28.83M	-34.15M	-46.98M	91.10M	-52.08M	-75.69M	-80.16M	-90.59M	-120.60M
Share-based Compensation (Quarter)	0.71M	0.93M	0.96M	1.66M	2.02M	2.45M	2.75M	2.67M	2.68M	2.92M	3.22M	4.12M	4.87M	5.59M	6.22M	7.74M	9.47M	9.74M	10.96M	13.21M
Gains from Sales and Divestitures (Quarter)		0.04M	0.04M	0.02M	0.04M	0.06M	0.08M		0.00M	0.07M	0.07M	938.00	0.00M	0.11M	0.11M	0.09M	0.09M	0.12M	0.15M	0.24M
Gains from Investment Securities (Quarter)	0.03M	1.19M	15.96M	0.02M	0.01M	0.20M	2.30M	3.00M	0.04M	0.05M	0.20M	0.71M	10.60M	3.50M	12.10M	0.10M	1.00M	0.10M	8.20M	4.40M
Cash from Restructuring (Quarter)	0.16M	0.12M	0.12M
Non-cash Items (Quarter)		0.08M	0.47M	0.67M	1.04M	1.10M	1.15M	1.41M	1.85M	2.21M	2.61M	2.18M	2.37M	2.65M	172.63M	3.10M	3.56M	4.00M	260.70M	169.47M
Cash from Operations (Quarter)	-7.67M	-5.48M	-6.44M	-8.98M	-19.03M	-18.42M	-21.16M	-26.29M	-17.77M	-22.97M	-25.14M	-33.83M	-24.78M	-36.88M	-39.18M	-54.41M	-54.80M	-61.91M	-69.99M	-106.50M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)				0.56M	0.55M	0.56M	0.59M	0.58M	0.56M	0.55M	0.53M	0.52M	0.50M	0.50M	0.55M	0.46M	0.44M	0.43M	0.11M	0.12M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.05M	0.06M	0.03M	0.01M	-0.11M	-0.15M	-0.60M	-0.51M	0.52M	0.01M	0.00M	0.01M	0.01M	0.02M	0.06M	0.09M	0.12M	0.13M	0.14M	0.14M
Change in Working Capital
Change in Account Payables (Quarter)	1.01M	-0.76M	0.42M	5.94M	-0.24M	-0.07M	4.98M	-6.67M	7.95M	-0.98M	-1.18M	-5.91M	-0.55M	-0.06M	3.06M	1.60M	3.90M	4.79M	3.62M	-7.97M
Change in Accured Expenses (Quarter)	0.08M	1.02M	3.22M	4.22M	-2.41M	0.47M	4.75M	4.64M	-4.61M	-1.19M	-1.05M	-1.69M	4.58M	8.07M	-3.77M	-4.78M	8.10M	3.92M	7.21M	-0.44M
Other Working Capital Changes (Quarter)	-0.13M	3.01M	-3.01M	-0.27M	0.30M	7.67M	0.48M	-0.68M	0.95M	-2.27M	-0.65M	0.39M	-0.41M	-1.86M	0.90M	5.88M	-6.74M	4.42M	0.37M	-0.18M
Investing Activities
Capital Expenditures (Quarter)				0.02M	0.01M	0.04M					0.06M		0.09M	0.24M	0.65M	0.19M	0.21M	0.13M	0.10M	0.02M
Change in Acquisitions & Divestments (Quarter)					16.00M	38.00M	24.00M	36.90M	22.40M	44.90M	71.82M	31.68M	58.50M	111.50M	73.28M	106.25M	126.06M	168.59M	105.27M	87.92M
Cash from Investing Activities (Quarter)	0.80M		-5.00M	-39.45M	-42.09M	-2.44M	13.44M	12.23M	-86.45M	16.23M	18.56M	-219.29M	-22.68M	38.32M	-221.38M	15.32M	28.54M	69.76M	80.66M	-137.82M
Financing Activities
Other financing activities (Quarter)	2.40M					-6.10M
Cash from Financing Activities (Quarter)	48.99M		4.92M	80.27M	0.05M	0.91M	20.71M	107.98M	0.43M	0.30M	24.83M	276.54M	3.44M	0.74M	325.95M	1.53M	20.29M	0.80M	286.28M	3.94M
Additional items
Change in Cash (Quarter)	42.12M	-5.48M	-6.52M	31.83M	-61.08M	-19.95M	12.98M	93.93M	-103.79M	-6.45M	18.24M	23.42M	-44.02M	2.17M	65.39M	-37.56M	-5.97M	8.65M	296.95M	-240.37M
Free Cash Flow (Quarter)	-7.67M	-5.48M	-6.44M	-9.00M	-19.04M	-18.46M	-21.16M	-26.29M	-17.77M	-22.97M	-25.21M	-33.83M	-24.87M	-37.12M	-39.83M	-54.59M	-55.01M	-62.04M	-70.10M	-106.52M
Net Cash Flow (Quarter)	42.12M	-5.48M	-6.52M	31.83M	-61.08M	-19.95M	12.98M	93.93M	-103.79M	-6.45M	18.24M	23.42M	-44.02M	2.17M	65.39M	-37.56M	-5.97M	8.65M	296.95M	-240.37M

Research Tools

Vera Therapeutics Cash Flow Statement (2020-2026) | VERA

Create an account

Sign In

Reset Password